يعرض 1 - 20 نتائج من 67 نتيجة بحث عن '"Pyrazines/pharmacology"', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Prekovic , S , Schuurman , K , Mayayo-Peralta , I , Manjón , A G , Buijs , M , Yavuz , S , Wellenstein , M D , Barrera , A , Monkhorst , K , Huber , A , Morris , B , Lieftink , C , Chalkiadakis , T , Alkan , F , Silva , J , Győrffy , B , Hoekman , L , van den Broek , B , Teunissen , H , Debets , D O , Severson , T , Jonkers , J , Reddy , T , de Visser ....

    وصف الملف: application/pdf

  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Kihyun Kim, Seok Jin Kim, Verena Voelter, Cheolwon Suh, Sung-Soo Yoon, Je-Jung Lee, Jae-Yong Kwak, Hun-Mo Ryoo, Yang Soo Kim, Joon Ho Moon, Seong Kyu Park, Sung-Hyun Kim, Yeung-Chul Mun, Jin Seok Kim, Hyeon-Seok Eom, Deog-Yeon Jo, Hyun Jung Jun, Ki-Hwan Kim, Jeong-Ok Lee, Jae Hoon Lee, Chang-Ki Min, Kim, Jin Seok

    وصف الملف: 113~121

    Relation: ANNALS OF HEMATOLOGY; J00161; OAK-2014-03061; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138794; http://link.springer.com/article/10.1007%2Fs00277-013-1893-z; T201405622; ANNALS OF HEMATOLOGY, Vol.93(1) : 113-121, 2014

  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المساهمون: 신동인, 이순태, 주건, 정근화, 김은희, 김정민, 박동규, 송은철, 김병수, 윤성수, 김만호, 노재규

  14. 14

    المساهمون: Hubrecht Institute for Developmental Biology and Stem Cell Research, Graduate School, Pathology, CCA - Cancer biology and immunology

    المصدر: Gastroenterology, 157(4), 1153-1155.e1. W.B. Saunders Ltd

  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18

    المساهمون: Instituto de Investigação e Inovação em Saúde

    المصدر: Biomolecules
    Biomolecules, Vol 9, Iss 8, p 384 (2019)
    Volume 9
    Issue 8

    مصطلحات موضوعية: Photosensitizing Agents / pharmacology, Chemiluminescence, Cell Survival / drug effects, Pyrazines / pharmacology, photosensitizer, medicine.medical_treatment, lcsh:QR1-502, Antineoplastic Agents / pharmacology, Photodynamic therapy, 02 engineering and technology, chemotherapy, 01 natural sciences, Biochemistry, lcsh:Microbiology, Prostate cancer, Breast cancer, Prostate, Tumor Cells, Cultured, anticancer drug, Photosensitizer, Antineoplastic Agents / chemical synthesis, Pyrazines / chemical synthesis, health care economics and organizations, Photosensitizing Agents, Molecular Structure, Multidrug combinations, Imidazoles, prostate cancer, 021001 nanoscience & nanotechnology, 3. Good health, medicine.anatomical_structure, photodynamic therapy, Pyrazines, PC-3 Cells, MCF-7 Cells, 0210 nano-technology, medicine.drug, Antineoplastic Agents / chemistry, Imidazoles / pharmacology, Combination therapy, Cell Survival, Antineoplastic Agents, 010402 general chemistry, Article, breast cancer, Photosensitizing Agents / chemical synthesis, medicine, Chemotherapy, Humans, Photosensitizing Agents / chemistry, Molecular Biology, multidrug combinations, Cell Proliferation, business.industry, Cancer, Imidazoles / chemical synthesis, Anticancer drug, medicine.disease, Imidazoles / chemistry, chemiluminescence, 0104 chemical sciences, Photochemotherapy, Cancer research, Pyrazines / chemistry, Cell Proliferation / drug effects, Drug Screening Assays, Antitumor, business, Tamoxifen

    وصف الملف: application/pdf

  19. 19

    المساهمون: Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Centre de Physiopathologie de Toulouse-Purpan (INSERM U563 - CNRS UMR1037), Centre National de la Recherche Scientifique (CNRS)-Centre de lutte contre le cancer (CLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Institut Claudius Regaud, This work was supported by the CNRS, by grants from the Fonds Sociaux Européens and the Ligue contre le Cancer (MM), and in part by grants from the Région Midi-Pyrénées and the Génopole Toulouse Midi-Pyrénées., The authors would like to thank Millennium Pharmaceuticals for their generous gift of bortezomib and are very grateful to Dr. C. Demur for helpful assistance in managing the patient samples used in this study.

    المصدر: Leukemia Research
    Leukemia Research, Elsevier, 2010, 34 (4), pp.498-506. ⟨10.1016/j.leukres.2009.09.020⟩

    مصطلحات موضوعية: Proteomics, Male, Cancer Research, Leupeptins, MESH: Drug Resistance, Neoplasm / drug effects, MESH: Leukemia, Myeloid, Acute / metabolism, Apoptosis, MESH: Proteasome Endopeptidase Complex / metabolism, Proteasome regulators, Bortezomib, MESH: Aged, 80 and over, 0302 clinical medicine, Tumor Cells, Cultured, MESH: Bortezomib, MESH: Aged, Aged, 80 and over, MESH: Proteasome Endopeptidase Complex / analysis, 0303 health sciences, MESH: Middle Aged, MESH: Leukemia, Myeloid, Acute / pathology, U937 cell, Myeloid leukemia, U937 Cells, Hematology, Middle Aged, Cell cycle, Prognosis, Boronic Acids, 3. Good health, Leukemia, Myeloid, Acute, Oncology, Pyrazines, 030220 oncology & carcinogenesis, MESH: Pyrazines / pharmacology, Female, MESH: Daunorubicin / pharmacology, Proteasome Inhibitors, medicine.drug, Adult, Proteasome Endopeptidase Complex, MESH: Protease Inhibitors / pharmacology, Daunorubicin, Antineoplastic Agents, HL-60 Cells, MESH: U937 Cells, Biology, MESH: Prognosis, 03 medical and health sciences, MESH: Leukemia, Myeloid, Acute / diagnosis, MESH: Proteasome Inhibitors, MESH: Apoptosis / drug effects, MESH: HL-60 Cells, medicine, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Protease Inhibitors, MESH: Tumor Cells, Cultured, Aged, 030304 developmental biology, MESH: Humans, Mass spectrometry, MESH: Drug Resistance, Neoplasm / physiology, MESH: Leupeptins / pharmacology, MESH: Adult, MESH: Boronic Acids / pharmacology, 2D gel electrophoresis, MESH: Antineoplastic Agents / pharmacology, MESH: Male, 20S proteasome, Proteasome, Drug Resistance, Neoplasm, Proteasome inhibitor, Cancer research, MESH: Female

  20. 20

    المساهمون: Immunobiologie des Cellules Dendritiques, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Histopathologie humaine et Modèles animaux, Institut Pasteur [Paris] (IP), Funding was provided by the Institut Pasteur (Pasteur-Roux post-doctoral fellowship to R.B.d.S.), the Pasteur Foundation (fellowship to M.E.L.), the Ligue Contre le Cancer (M.L.A.), the Fondation ARC pour la recherche sur le cancer (M.L.A.) and the French government's Invest in the Future Program, managed by the Agence Nationale de la Recherche (LabEx Immuno-Onco (R.B.d.S., M.E.L., N.Y., M.A.I. and M.L.A.))., ANR-11-IDEX-0005,USPC,Université Sorbonne Paris Cité(2011), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris]

    المصدر: Nature Immunology
    Nature Immunology, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩
    Nature Immunology, Nature Publishing Group, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩

    مصطلحات موضوعية: Male, Adoptive cell transfer, Lymphocyte, medicine.medical_treatment, Cancer immunotherapy, MESH: Flow Cytometry, CXCR3, MESH: Mice, Knockout, MESH: Cell Movement/drug effects, 0302 clinical medicine, Cell Movement, MESH: Triazoles/pharmacology, Immunology and Allergy, MESH: Animals, MESH: Chemokines/metabolism, Lymphocytes, Mice, Knockout, Mice, Inbred BALB C, 0303 health sciences, Chemistry, Flow Cytometry, Adoptive Transfer, 3. Good health, MESH: Dipeptidyl Peptidase 4/immunology, medicine.anatomical_structure, MESH: Neoplasms, Experimental/genetics, MESH: Dipeptidyl Peptidase 4/genetics, MESH: Pyrazines/pharmacology, Pyrazines, 030220 oncology & carcinogenesis, MESH: Neoplasms, Experimental/immunology, MESH: Chemokine CXCL10/metabolism, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Immunotherapy, Chemokines, MESH: Chemokine CXCL10/immunology, Receptors, CXCR3, MESH: Cell Line, Tumor, MESH: Mice, Transgenic, Dipeptidyl Peptidase 4, T cell, Immunology, MESH: Mice, Inbred BALB C, MESH: Immunotherapy/methods, MESH: Cell Movement/immunology, Mice, Transgenic, MESH: Receptors, CXCR3/immunology, 03 medical and health sciences, Immune system, MESH: Mice, Inbred C57BL, Cell Line, Tumor, MESH: Lymphocytes/metabolism, medicine, Animals, CXCL10, MESH: Sitagliptin Phosphate, 030304 developmental biology, MESH: Neoplasms, Experimental/therapy, Dipeptidyl-Peptidase IV Inhibitors, Protein transport, MESH: Dipeptidyl-Peptidase IV Inhibitors/pharmacology, Sitagliptin Phosphate, Neoplasms, Experimental, Triazoles, MESH: Male, Chemokine CXCL10, Mice, Inbred C57BL, MESH: Adoptive Transfer, MESH: Receptors, CXCR3/metabolism, MESH: Dipeptidyl Peptidase 4/metabolism, MESH: Lymphocytes/immunology, MESH: Female, MESH: Chemokines/immunology